LIF has been reported to promote the progression of malignancies of many solid tumors, including rhabdomyosarcoma, choriocarcinoma, melanoma, breast cancer and colorectal cancer [8, 10, 12–17]. The gene discussed is LIF; the disease is breast carcinoma.